IMDRF Predetermined Change Control Plans (PCCP) 2026: Medical Device Regulatory Compliance & Global Implementation Guide

How IMDRF PCCP Principles, FDA Requirements, AI/ML Device Updates, Risk-Based Change Management, and Total Product Lifecycle Strategies Are Shaping Medical Device Regulation

The International Medical Device Regulators Forum (IMDRF) has finalized a technical document outlining principles that regulatory authorities can consider when developing requirements for Predetermined Change Control Plans (PCCPs).

PCCPs are increasingly important for medical devices that require planned modifications after authorization, particularly software and AI/ML-enabled devices. The approach allows manufacturers to define anticipated changes, the methodology for implementing and validating those changes, and appropriate evidence for demonstrating continued safety and effectiveness.

The growing international focus on PCCPs is creating a more predictable framework for managing medical device modifications while supporting innovation and efficient regulatory oversight.

Why PCCP Compliance Is Becoming a Strategic Priority

Medical device software, AI, and machine-learning technologies can evolve rapidly aftermarket authorization.

Traditional regulatory processes may require additional submissions when significant modifications are introduced. PCCPs provide a structured approach for managing predefined changes within an agreed regulatory framework.

Key benefits include:

• More predictable change management
• Reduced regulatory uncertainty
• Faster implementation of planned modifications
• Continued safety and effectiveness
• Better lifecycle management
• Improved regulatory transparency
• Support for software and AI innovation
• Greater international regulatory alignment

Without appropriate PCCP planning, manufacturers may face:

• Additional regulatory submissions
• Delayed software updates
• Increased compliance costs
• Unclear change-control pathways
• Repeated regulatory interactions
• Lifecycle-management challenges

Executive Overview

A robust PCCP strategy should be integrated:

• Regulatory requirements
• Planned device modifications
• Modification boundaries
• Change-control methodology
• Risk management
• Verification and validation
• Performance monitoring
• Clinical considerations where applicable
• Cybersecurity considerations
• Software lifecycle management
• Documentation
• Post-market surveillance
• Total Product Lifecycle (TPLC) management

Manufacturers should establish PCCPs early enough to support their product development and regulatory strategy.

Understanding Predetermined Change Control Plans

A Predetermined Change Control Plan describes anticipated device modifications and establishes the methodology for developing, validating, and implementing those modifications.

The objective is to allow predefined changes to be managed within an approved regulatory framework while maintaining reasonable assurance of safety and effectiveness.

PCCPs are particularly relevant to:

• AI-enabled medical devices
• Machine-learning-enabled devices
• Software as a Medical Device (SaMD)
• Software-driven medical devices
• Adaptive algorithms
• Continuously improving technologies
• Device-led combination products

FDA's PCCP framework specifically describes the planned modifications, methodology for implementing them, and assessment of their impact.

IMDRF's Role in PCCP Harmonization

IMDRF's technical work is significant because it provides principles that regulators can consider when developing their own PCCP requirements.

The objective is to encourage greater consistency across regulatory jurisdictions while allowing individual authorities to establish country-specific requirements.

This supports:

• Regulatory harmonization
• Consistent terminology
• Risk-based change management
• Predictable regulatory pathways
• International product development
• Greater regulatory efficiency

IMDRF's PCCP work builds on earlier international collaboration involving regulators such as FDA, Health Canada, and the UK's MHRA on PCCP principles for machine-learning-enabled medical devices. FDA has highlighted that these principles emphasize focused, risk-based, evidence-based, transparent, and lifecycle-oriented PCCPs.

Key Elements of a Medical Device PCCP

A strong PCCP should clearly define:

1. Planned Modifications

Manufacturers should identify the types of changes expected during the device lifecycle.

Examples may include:

• Software updates
• Algorithm modifications
• Performance improvements
• User-interface changes
• Data updates
• Model updates
• Cybersecurity-related changes

2. Modification Methodology

The PCCP should explain how proposed changes will be:

• Developed
• Tested
• Verified
• Validated
• Implemented
• Monitored

3. Impact Assessment

Manufacturers should evaluate how planned changes may affect:

• Safety
• Effectiveness
• Performance
• Intended use
• Risk profile
• Clinical performance
• Cybersecurity
• Usability

Risk Management and PCCP

Risk management is central to PCCP development.

Manufacturers should evaluate:

• Hazard identification
• Risk estimation
• Risk controls
• Residual risk
• Benefit-risk considerations
• Change-specific risks
• New failure modes
• Performance degradation

PCCPs should establish clear boundaries so that changes remain within the scope of the approved plan.

AI and Machine Learning Medical Devices

PCCPs are particularly relevant to AI/ML-enabled medical devices because these technologies may require iterative updates.

FDA finalized specific PCCP guidance for AI-enabled device software functions, recommending that PCCPs describe planned modifications, the methodology for developing, validating, and implementing them, and an assessment of their impact.

Manufacturers should consider:

• Algorithm changes
• Model retraining
• Dataset updates
• Performance monitoring
• Bias and representativeness
• Model drift
• Validation datasets
• Clinical performance
• Cybersecurity
• Human factors

FDA PCCP Regulatory Framework

FDA has been actively developing its PCCP framework for medical devices.

FDA's draft guidance for medical devices proposes that PCCPs be reviewed as part of marketing submissions and used to support planned modifications without requiring a separate marketing submission for every modification covered by the approved plan.

FDA's 2025 final guidance specifically addresses PCCPs for AI-enabled device software functions.

The framework applies across relevant device pathways, including:

• 510(k)
• De Novo
• PMA

where applicable to the device and submission strategy.

FDA Legislative Foundation

The Food and Drug Omnibus Reform Act of 2022 gave FDA express authority related to PCCPs.

This legislative development strengthened the regulatory foundation for accepting predetermined change strategies and supported FDA's subsequent guidance development.

FDA has described the PCCP approach as part of its broader effort to support safe and effective innovation in AI-enabled medical devices.

PCCP and Total Product Lifecycle Management

PCCP development should be connected to the entire product lifecycle.

Manufacturers should consider:

• Product development
• Regulatory submission
• Design changes
• Software updates
• Verification and validation
• Production
• Post-market monitoring
• Complaint handling
• CAPA
• Risk management
• Periodic performance review
• Product retirement

This lifecycle approach can help manufacturers maintain regulatory control as technologies evolve.

PCCP Documentation Requirements

Manufacturers should establish clear documentation covering:

• Device description
• Intended use
• Planned modifications
• Modification boundaries
• Change methodology
• Risk assessment
• Verification and validation
• Performance evaluation
• Acceptance criteria
• Monitoring plans
• Implementation procedures
• Change-control records

Documentation should be sufficiently specific for regulators to understand what changes are covered and how they will be controlled.

Verification and Validation

PCCP implementation should include appropriate verification and validation activities.

Companies should define:

• Test methods
• Acceptance criteria
• Validation datasets
• Performance thresholds
• Regression testing
• Clinical evaluation where applicable
• Cybersecurity testing
• Usability assessment
• Post-implementation monitoring

The level of evidence should be proportionate to the risks associated with the planned modification.

Change Control and Quality Systems

PCCPs should be integrated into established quality-management systems.

Relevant processes include:

• Design control
• Software lifecycle management
• Change control
• Risk management
• CAPA
• Document control
• Configuration management
• Verification and validation
• Supplier management
• Complaint handling
• Post-market surveillance

This ensures that PCCP implementation does not operate separately from the manufacturer's existing quality framework.

PCCP and Cybersecurity

For connected and software-based devices, cybersecurity should be considered when defining planned modifications.

Manufacturers should evaluate:

• Security vulnerabilities
• Software dependencies
• Access controls
• Threat modeling
• Security testing
• Patch management
• Data protection
• System integrity
• Post-update monitoring

Cybersecurity changes should remain consistent with the boundaries and methodology established in the PCCP.

Regulatory Submission Strategy

Manufacturers should determine early whether a PCCP should be incorporated into the applicable marketing submission.

A regulatory strategy should address:

• Device classification
• Applicable pathway
• Planned modifications
• PCCP scope
• Supporting evidence
• Risk assessment
• Verification and validation
• Regulatory interactions
• Post-market responsibilities

Early regulatory engagement can help clarify whether planned modifications are appropriate for inclusion within a PCCP.

Common PCCP Challenges

Manufacturers may encounter:

• Unclear change boundaries
• Overly broad PCCPs
• Insufficient risk assessment
• Inadequate validation methodology
• Weak performance monitoring
• Poor documentation
• Inconsistent lifecycle controls
• Regulatory uncertainty
• AI/ML model drift
• Dataset limitations
• Cybersecurity concerns
• Cross-jurisdictional differences

Common Mistakes to Avoid

Companies should avoid:

• Defining changes too broadly
• Failing to establish clear boundaries
• Treating PCCP as a standalone document
• Weak risk management
• Insufficient validation
• Poor acceptance criteria
• Ignoring post-market monitoring
• Failing to address cybersecurity
• Inadequate documentation
• Not considering international requirements
• Assuming every future change can be covered

PCCP Implementation Roadmap

Regulatory Intelligence and Global Harmonization

Companies developing medical devices for multiple markets should monitor:

• IMDRF developments
• FDA PCCP guidance
• AI/ML regulatory guidance
• Health Canada developments
• MHRA requirements
• Software medical device regulations
• Cybersecurity requirements
• Quality-system expectations
• Post-market surveillance requirements

A harmonized regulatory strategy can reduce duplication while recognizing jurisdiction-specific requirements.

Business Benefits

Frequently Asked Questions

1. What is PCCP?

A Predetermined Change Control Plan defines planned device modifications and the methodology for developing, validating, and implementing them.

2. Why are PCCPs important?

They can provide a structured pathway for managing predefined device changes while maintaining safety and effectiveness.

3. Which devices can benefit from PCCPs?

They are particularly relevant to AI/ML-enabled devices, SaMD, software-driven devices, and technologies requiring iterative updates.

4. What should a PCCP contain?

It should define planned modifications, change boundaries, methodology, risk assessment, verification and validation, and impact assessment.

5. Does FDA recognize PCCPs?

Yes. FDA has express statutory authority related to PCCPs and has issued guidance addressing PCCPs for medical devices and AI-enabled device software functions.

6. Does a PCCP eliminate all future regulatory submissions?

No. Only modifications appropriately covered by an accepted PCCP may be managed under that framework. Changes outside the approved scope may require additional regulatory assessment or submission.

7. Why is PCCP important for AI/ML devices?

AI/ML technologies may require iterative updates, making predefined change and validation strategies particularly valuable.

8. What are the biggest PCCP challenges?

Key challenges include defining appropriate boundaries, risk assessment, validation, performance monitoring, documentation, cybersecurity, and jurisdiction-specific requirements.

9. Should PCCP be part of lifecycle management?

Yes. PCCP planning should connect premarket development with post-market change management and total product lifecycle activities.

10. How can Maven Regulatory Solutions help?

Maven Regulatory Solutions supports:

• PCCP regulatory strategy
• Medical device regulatory consulting
• AI/ML device compliance
• SaMD regulatory strategy
• PCCP gap assessments
• Risk-management support
• Verification and validation strategy
• Regulatory submission support
• Lifecycle management
• Regulatory intelligence
• Global regulatory consulting

Conclusion

PCCPs are becoming an important regulatory mechanism for managing planned medical device modifications, particularly as AI, machine learning, and software-based technologies evolve rapidly.

The IMDRF's work supports greater international alignment, while FDA's PCCP framework demonstrates how predefined modification strategies can be incorporated into medical device regulatory pathways. FDA's 2025 final guidance further strengthens the approach for AI-enabled device software functions.

Manufacturers should therefore treat PCCP development as part of their broader regulatory strategy, risk management, software lifecycle, verification and validation, quality system, and post-market management framework.

Early PCCP planning can improve regulatory predictability, support controlled innovation, reduce unnecessary regulatory delays, and strengthen long-term medical device lifecycle management.

Why Choose Maven Regulatory Solutions?

Maven Regulatory Solutions provides support for:

• PCCP regulatory strategy
• Medical device regulatory compliance
• AI/ML device regulatory strategy
• SaMD compliance
• PCCP gap assessments
• Risk management
• Verification and validation strategy
• Regulatory submission support
• Lifecycle management
• Regulatory intelligence
• Global regulatory consulting